Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had revenue of $662.72K in the quarter ending December 31, 2024. This brings the company's revenue in the last twelve months to $662.72K, down -832.17% year-over-year.

• Revenue (ttm): $662.72K
• Revenue Growth: -832.17%
• P/S Ratio: 12.94
• Revenue / Employee: $27,613
• Employees: 24
• Market Cap: 8.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	-	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	6.06M	5.13M	552.46%
Jun 30, 2021	928.07K	-2.06M	-68.98%
Jun 30, 2020	2.99M	-4.37M	-59.37%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.